0.92
price down icon2.25%   -0.0212
after-market 시간 외 거래: .90 -0.02 -2.17%
loading

Xilio Therapeutics Inc (XLO) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
3.55%
17.49
18.13 17.36 20.12 23.53
Operating Income/Loss
3.55%
-17.49
-18.13 -17.36 -20.12 -23.53
Nonoperating Income/Loss
40.21%
0.284
0.475 0.613 0.761 0.88
Income/Loss From Continuing Operations Before Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Income/Loss From Continuing Operations After Tax
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Net Income/Loss
2.56%
-17.20
-17.66 -16.75 -19.36 -22.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
135.87K%
27.91
0.0205 27.52 27.47 27.43
Basic Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Diluted Earnings Per Share
3.12%
-0.62
-0.64 -0.61 -0.70 -0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
자본화:     |  볼륨(24시간):